Clinical Trial Update: Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [Phase 3]

View source ↗

Summary

This document reports long-term immunogenicity and safety results from a Phase 3 trial of the MMRV vaccine, evaluating durability of immune response and safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• MMRV vaccine (Measles, Mumps, Rubella, Varicella Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rubella, Varicella | Phase 3 | Status: COMPLETED